[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
Next Article in Journal
Designing a Tactile Document UI for 2D Refreshable Tactile Displays: Towards Accessible Document Layouts for Blind People
Previous Article in Journal
Bridging the Gap: Virtual Reality as a Tool for De-Escalation Training in Disability Support Settings
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
MTI
Volume 8
Issue 11
10.3390/mti8110101
mti-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Interactive Conversational Agents for Cigarette-Smoking and Vaping Cessation: A Mixed-Methods Systematic Review

by
Anthony Lachance
1,
Sié Mathieu Aymar Romaric Da
2,
Achille Yameogo
2,
James Plaisimond
2,
Florian Naye
3,
Farzaneh Yousefi
1,
Frédéric Bergeron
1,
Maxime Sasseville
1,2 and
Marie-Pierre Gagnon
1,2,*
1
Faculty of Nursing Sciences, Université Laval, 2325 Rue de l’Université, Québec, QC G1V 0A6, Canada
2
VITAM Research Center, 2480 Chemin de la Canardière, Québec, QC G1J 2G1, Canada
3
Faculty of Health Sciences, Université de Sherbrooke, 3001 12 Ave N Immeuble X1, Sherbrooke, QC J1K 2R1, Canada
*
Author to whom correspondence should be addressed.
Multimodal Technol. Interact. 2024, 8(11), 101; https://doi.org/10.3390/mti8110101
Submission received: 26 September 2024 / Revised: 26 October 2024 / Accepted: 4 November 2024 / Published: 8 November 2024
Browse Figures
Graphical abstract
"> Figure 1
<p>PRISMA flow diagram for inclusion of studies.</p> ">
Versions Notes

Abstract

:
Interactive conversational agents, also known as chatbots, have the potential to increase the success rate of digital technology interventions to promote healthy behaviors. However, due to their newness and limited use, little is known about their integration, usefulness, and effectiveness in promoting smoking and vaping cessation. The aim of this mixed-methods systematic review was to assess the effectiveness and characteristics of current interactive conversational agents in promoting and supporting smoking and vaping cessation. A mixed-methods systematic review was conducted to identify studies published in the last 20 years in five relevant databases. Eight studies, including seven on smoking cessation and one on smoking and vaping cessation, were included. The results showed that, compared to other smoking cessation methods, chatbots can lead to better engagement in treatment, resulting in higher rates of sustained abstinence and improved quality of life. In addition, chatbots can be perceived as empathetic and establish a decent therapeutic alliance thanks to their communication skills. This knowledge could be useful for the development of interactive conversational agents to support smoking and/or vaping cessation. Alternative intervention tools targeting younger generations, such as chatbots, may offer an additional way for public health professionals to reach them.

Graphical Abstract">

Graphical Abstract

1. Introduction

Smoking is a major public health problem, responsible for the deaths of more than eight million people worldwide each year [1]. Lung cancer caused by direct exposure to cigarette smoke is responsible for these deaths [2,3], but up to 1.2 million of them are caused by passive smoking [1]. Smoking cessation is therefore a first-line intervention to reduce lung cancer and smoking-related mortality [4]. The rapidly growing use of electronic cigarettes (e-cigarettes) and vaping devices for nicotine consumption, especially among young people, is raising new public health concerns [5,6]. The number of e-cigarette users worldwide was estimated to be 82 million in 2021 [7]. Furthermore, according to the World Health Organization (WHO), e-cigarette use among adolescents exceeds that of adults [8]. Vaping has been linked to mental health problems such as attention problems, personality changes, learning difficulties, and sleep problems [9,10]. Young people are more vulnerable than adults to the neurological effects of nicotine in e-cigarettes [11]. Vaping may also increase the risk of developing diseases such as recurrent spontaneous pneumothorax, chronic obstructive pulmonary disease, and asthma [12,13,14]. The evolution of digital technologies offers new perspectives for health promotion and preventive health interventions [15]. Interventions aimed at preventing smoking and/or vaping are benefiting from this evolution due to new generations’ familiarity with technology [16,17]. Interactive conversational agents, also known as chatbots, are computer programs that use natural language processing to engage in conversations with humans to provide or gather information [18,19,20]. Chatbots use algorithms to simulate a human conversation via text or voice messages. They are easy to use and require minimal computer knowledge and skills [21,22]. Chatbots can use simple, pre-determined conversational algorithms to simulate a conversation, or more complex systems based on neural networks and deep learning to understand speech, produce a vocal response, and simulate social interaction [23]. Interactive chatbots enable automated interventions with customizable, accessible, and inexpensive software [24].
A recent review examined the acceptability and effectiveness of conversational agents to help people quit smoking [25], but did not consider vaping cessation. In addition, this review did not focus on interactive chatbots, which are likely to be more effective than traditional chatbots [24]. The present review focuses on chatbots that can adapt and simulate interactive conversations, as opposed to conversational agents that offer users limited multiple-choice options, thus reducing the impression of real, meaningful interactions.
The aim of this mixed-methods systematic review is to assess the effectiveness and characteristics of interactive conversational agents in promoting smoking and vaping cessation.

2. Materials and Methods

This mixed-methods systematic review grew out of a broader scoping review of interactive conversational agents used for health promotion, prevention, and care [26]. This review focuses on a sub-analysis of studies that included the use of an interactive conversational agent or chatbot to promote smoking cessation or vaping cessation. The protocol was prospectively registered in the Open Science Framework (OSF) [27]. According to the registered protocol, a scoping review was initially planned before conducting this systematic review. The scoping part aimed to assess the scope of available studies on chatbots for vaping cessation, as this is an emerging field. However, due to the limited number of studies on chatbot interventions for vaping cessation, the scoping review phase was integrated into the final systematic review. Our review questions were: (1) what is the effectiveness of interactive conversational agents for smoking and vaping cessation compared with other alternatives? and (2) what is the benefit of integrating these technologies into smoking and vaping cessation interventions? A mixed-methods systematic review was conducted according to the framework of Stern et al. [28]. The PRISMA-ScR (preferred reporting items for systematic reviews and meta-analyses extension for scoping reviews) criteria were used to report the results [29].
We considered all types of evidence that met the PICOS criteria (population, intervention, comparator, outcomes, setting or context):
  • Participants or population: We included all studies with lay participants (e.g., patients, students, citizens). Studies targeting only healthcare providers were excluded.
  • Interventions or phenomena of interest: We included all interactive conversational agents, i.e., those that involve a two-way exchange (written, oral, or visual dialogue), aimed at laypeople for smoking or vaping cessation.
  • Comparator: We did not apply any restrictions.
  • Outcomes: We considered all outcomes reported in the trials. We looked for outcomes related to cigarette and e-cigarette smokers. These outcomes included barriers, facilitators, acceptability, feasibility, adoption, compliance, motivation to quit, abstinence rates, quit rates, smoking/vaping-related disease morbidity, quality of life, satisfaction, cost and cost-effectiveness.
  • Setting: We included trials conducted in all settings. All study types were included (qualitative, quantitative, and mixed methods).
The search strategy of the broader scoping review was reused, and terms related to smoking and vaping cessation were added. The original and modified versions of the search strategy were developed in collaboration with a university librarian (FB) experienced in systematic reviews. We conducted an iterative review process with the research team. All relevant comments were incorporated into the final version of the search strategy and approved by all team members. We developed a specific search strategy for each of the following databases: MEDLINE (Ovid), Embase, CINAHL, Web of Science, and Inspec (Engineering Village). The search strategy is presented in Appendix A.1, Appendix A.2, Appendix A.3, Appendix A.4 and Appendix A.5. The search was limited to studies from the last 20 years due to the recent nature of conversational agents, and no linguistic restrictions were applied to the search. We used terms such as chatbot, conversational agent, virtual embodied agent, and their spelling variants. In addition, as innovation implementations are often driven by the private sector, we conducted an Internet search of the following sources and databases: Google, Google Scholar, Institut national d’excellence en santé et en services sociaux, Canadian Evaluation Society, EuroScan, OpenGrey, Grey Literature Report, GreyNet, and Grey Matters. We conducted backward handsearching for other relevant references.
A search of the various databases included in the search strategy identified 148 publications. We exported all citations resulting from the application of the updated search strategy to Covidence [30], where duplicates were removed by its automated function. Pairs of reviewers (AL, AY, JP, SD, FN, FY) performed an independent blinded assessment of inclusion criteria based on titles and abstracts. The reviewers searched for and obtained all full texts of the selected references and imported the files into Covidence. The same reviewers performed an independent blinded assessment of the full texts. Reasons for exclusion were recorded in Covidence and reported in the flowchart. We used the PRISMA diagram to describe the search strategy, selection process, and reasons for exclusion [31]. The PRISMA diagram is shown in Figure 1.
We developed an extraction grid and tested it on an article during a team meeting. Team members completed the extraction, and the data quality was validated by an experienced researcher (MPG). We extracted descriptive data (title, year of publication, authors, country), study type (published or gray literature, study design), intervention data (technology name, technology language, delivery channel, and features such as audio, text, voice, avatar), setting data (target population, delivery site), sample data (comparators, number of participants, sample sizes), outcomes (processes, patients, providers, or systems), and type of outcome (qualitative and quantitative).
We presented the data synthesis with a narrative summary of the differences and similarities between interventions, highlighting strengths and weaknesses, key findings, key resources used, and trade-offs. We also compared the direction of effects on primary and secondary outcomes in the included studies. We used a convergent approach to consider both qualitative and quantitative evidence.
We assessed the quality of the included studies using the Mixed-Methods Assessment Tool (MMAT) [32,33]. Pairs of reviewers performed a blinded methodological assessment. In case of disagreement, a third experienced reviewer (MPG) was consulted to reach a consensus.

3. Results

3.1. Overview

We identified 105 studies for review after excluding duplicates (see Figure 1). After the abstract review, 25 full-text articles were assessed for inclusion. After full-text review and conflict resolution, eight studies met our inclusion criteria [34,35,36,37,38,39,40,41]. The eight included studies were conducted in European (Netherlands, Spain, Switzerland, UK) and North American (Canada, USA) countries between 2018 and 2023. All used either a chatbot alone or another technology with a chatbot (e.g., an app) to promote smoking cessation. We found one study on the use of chatbots that promoted both smoking and vaping cessation [37]. This study targeted Swiss adolescents aged 16 to 19 years attending a vocational school. The remaining seven included studies [34,35,36,38,39,40,41] targeted all cigarette smokers aged 18 years and older for recruitment. The number of participants recruited ranged from 153 to 688 for the clinical trials [37,38,39,40] to over 50,000 for the community study [41]. One study [34] was a prospective cohort study targeting a specific population; therefore, recruitment was much lower (six participants). Another study [36] was a pre–post test study with recruitment of 349 participants. The last study [35] was qualitative and involved semi-structured interviews with a smaller population (14 participants). All chatbots in the included studies had chat (text) functionality, two of them also had audio [34,40] and/or voice functionality [40,41], only one [34] included an avatar, and another [37] included a quiz. Furthermore, in three studies [34,35,36], the chatbot used in the intervention had no comparator. One study [37] compared the chatbot condition with the condition without a chatbot. One study [38] compared a motivational interviewing (MI) chatbot with a neutral chatbot, whereas another study [39] compared a motivational interviewing chatbot with a confrontational advice chatbot. On the other hand, one study [40] compared a chatbot with usual clinical practice for smoking cessation, and the last study [41] compared an app with an integrated chatbot with the same app without the integrated chatbot. The characteristics of the studies are shown in Table 1.

3.2. Outcomes Measured

The reported effects of interventions on patient outcomes are shown in Table 2. One study [36] evaluated the impact of several versions of a motivational interviewing-focused chatbot using generative thinking on smokers’ progress toward a decision to quit. MI is a counseling approach that helps patients increase their motivation to change unhealthy behaviors, including addictions, by encouraging them to reflect on the roots of a behavior and guiding them to overcome their ambivalence [42]. The study assessed participants’ willingness to quit smoking through three attributes: confidence, importance, and willingness. Only the fourth version (v5.2), showed a positive result for the three variables assessing willingness to quit smoking. In addition to the improved reflection generator, this version extended interaction on some of the questions. The same study also showed that the chatbot with deep reflection and extended conversations had a positive effect on perceived empathy, compared to the chatbot without generative reflection. Haug et al. [37] evaluated the reduction of addictive behaviors, specifically smoking and/or vaping. The use of the chatbot did not show a positive effect on reducing smoking and/or vaping. Of these eight studies, only one [39] assessed smoking cessation intentions by comparing the use of an MI-based chatbot with a confrontational counseling-based chatbot. Neither chatbot communication style showed a significant effect on the intention to quit smoking. However, exposure to the chatbot, regardless of communication style, had a positive effect on smokers’ intention to quit. Two studies [40,41] showed a positive effect of the intervention on abstinence. In addition, one of the eight included studies [38] assessed motivation to quit smoking. Differences in scores were not statistically significant between groups but increases in motivation to quit were significant in both control and intervention groups. Three studies [38,40,41] measured engagement, with Olano-Espinosa et al. [40] and Perski et al. [41] showing a positive effect and He et al. [38] showing no difference in engagement in the intervention group compared to the control group. One study [38] measured the effect of an MI-based chatbot on therapeutic alliance and perceived empathy compared to a neutral chatbot, but found no significant difference. The same study [38] reported higher perceived communication competence of the chatbot in the intervention group compared to the control group. Quality of life was measured in only one study [40], where both intervention and comparator had a positive effect on quality of life, but the intervention had a smaller effect than the comparator.
Abdullah et al. [34] did not report patient outcomes but presented descriptive data from six participants on the feasibility and acceptability of smoking cessation promotion. This study showed that the conversational agent was acceptable to participants and helped them set a quit date. Five participants reduced the average number of cigarettes smoked, and three tried to quit after the intervention. In addition, five participants adopted stricter smoke-free rules in their homes during the intervention period [34]. The final study [35] did not report quantitative results. This study showed that many users attributed human-like characteristics, thoughts, and behaviors to the chatbot.
We originally planned to conduct meta-analyses in the review protocol, but outcome data were insufficient.

3.3. Methodological Quality Assessment

The MMAT evaluates five quality criteria for randomized controlled trials: adequate randomization of participants, comparability of groups at baseline, completeness of results, blinding of assessors, and adequate allocation of intervention to participants. The five studies with a randomized controlled trial design [37,38,39,40,41] did not meet the quality criterion of blinding of assessors and each received a score of 4/5. However, this indicates a high methodological quality of these studies. For non-randomized quantitative studies, the methodological quality criteria assessed by the MMAT were the following: representativeness of the target population, appropriateness of outcome measures and exposure to the intervention, completeness of results, consideration of confounders in study design and data analysis, and implementation of the intervention as planned. Of the three remaining studies, only one [36] followed a non-randomized quantitative design. In this study, the quality criterion for the consideration of confounders was not met, resulting in a score of 4/5. The methodological quality of this study was thus high. The prospective cohort study [34] used a descriptive quantitative model. To assess the methodological quality of quantitative descriptive studies, the quality criteria evaluated by the MMAT are the following: the relevance of the strategy to answer the research question, the representativeness of the sample, the appropriateness of the measures, the assessment of the risk of non-response bias, and the appropriate analysis to answer the research question. This study [34] received a score of 4/5 because of the risk of selection bias in the sampling method due to the incentives given to the participants. It is therefore possible that the sample is not representative of the target population. The last study [35] followed a qualitative design model. For qualitative studies, the MMAT assesses the following quality criteria: the appropriateness of the qualitative approach to answer the research question, the appropriateness of the qualitative data collection methods to answer the research question, the appropriateness of the findings to the data, the interpretation of the findings supported by the data collected, and the coherence between the sources, collection, analysis, and interpretation of the qualitative data. In this study [35], all the criteria for methodological quality were met, giving it a methodological quality score of 5/5. The assessment of the methodological quality of this study indicates that it is of very high methodological quality.

4. Discussion

4.1. Key Findings

Overview of the studies
This review aimed to describe current interactive conversational agents used in smoking and vaping cessation interventions, and to evaluate their features and effectiveness. Seven of the eight included studies targeted smoking among adult smokers using interactive conversational agents that were comparable in terms of features. The eighth study targeted both smoking and vaping among teenagers [37]. The eight studies did not address smoking, and vaping, in the same way in terms of parameters, comparators, and study designs. As a result, the primary and secondary outcomes reported in these studies were heterogeneous. This review considered all outcomes that could be sensitive to an interactive chatbot intervention according to predefined criteria. Reported outcomes included continued abstinence, motivation to quit, engagement, therapeutic alliance, perceived empathy, quality of life, readiness to quit, intention to quit, and reduction in smoking and vaping.
Abstinence
Two studies [40,41] showed a positive effect of the intervention on sustained abstinence. Perski et al. [36] measured self-reported abstinence at one month, while Olano-Espinosa et al. [40] measured continuous abstinence at six months using biochemically validated quit rates. Continuous abstinence has also been measured in previous systematic reviews of digital interventions for smoking cessation [43,44,45]. For example, Do et al. [43] reported that interactive, tailored, web-based programs showed increased cessation effects for interventions with 6-month follow-up and moderate increases in smoking cessation for interventions with less than 6-month follow-up. The results of our review tend to confirm these findings, but due to the limited number of included studies and the different measurement methods used, no definitive conclusions can be drawn regarding the effect of chatbots on abstinence.
Motivation to quit
Motivation to quit smoking was documented in a study comparing an MI-based chatbot with a neutral chatbot [38]. Participants in both conditions reported increased motivation to quit smoking after interacting with the chatbot. However, a previous systematic review of combined pharmacotherapy and behavioral interventions for smoking cessation [44] reported that motivation to quit was not considered an effect modifier for quit rates. This means that dropout rates were not significantly higher in the most motivated populations. Therefore, motivation to quit should be interpreted with caution in future smoking and vaping cessation studies.
Engagement, therapeutic alliance, and perceived empathy
Regarding engagement, Olano-Espinosa et al. [40] and Perski et al. [41] reported that the intervention chatbot led to better engagement in treatment compared to usual clinical practice and a regular smoking cessation app, respectively. The prospective cohort study by Abdullah et al. [34] also seems to suggest that participants were more engaged with their treatment when using the chatbot. On the other hand, He et al. [38] reported that participants who interacted with either the MI-based intervention chatbot or the neutral control chatbot perceived them as equally engaging and empathetic, and developed similar levels of the therapeutic alliance with them. In their study, He et al. [38] suggested that these results may be due to the interactions not being frequent or long enough for MI to have an impact. This hypothesis was also supported by a systematic review of the use of MI for smoking cessation by Lindson-Hawley et al. [45]. However, in the study by Brown et al. [36], the perceived empathy of the chatbot that integrated enhanced generative reflections and more extended interaction on specific topics was significantly higher than that of the chatbot that did not generate reflections. This difference appears to be related to the use of generative reflections as opposed to the scripted reflections and responses in He et al.’s study [38]. Alphonse et al. [35] indicated in their study results that the chatbot thought and behaved like a human. However, these results contradict the study by Bendotti et al. [46]. In their study, they reported that participants expressed that they felt like they were talking to a robot, and that they initially felt like they were talking to a human, but that errors in the chatbot’s responses diminished this effect, causing frustration that discouraged them from continuing to use it [46]. Their findings may be related to functionality issues that are not present in the chatbot in Alphonse et al.’s study [35]. Furthermore, He et al. [3] reported that the perceived communication competence of the conversational agent was positively associated with both the intervention and comparison chatbots. These findings suggest that chatbots, regardless of their conceptual framework, may provide sufficient support to be more effective smoking cessation tools than other common practices.
Quality of life
Quality of life (QoL) was only measured in the study by Olano-Espinosa et al. [40]. Although there was no statistically significant difference between the groups in terms of smoking cessation rates, QoL was further improved among participants assigned to the chatbot compared to usual clinical practice. However, according to this study [40], this result does not necessarily mean that the chatbot itself had a better effect on QoL, as it could be related to the higher abstinence rates observed in the intervention group.
Readiness/intention to quit and smoking/vaping reduction
Finally, while Brown et al. [36] demonstrated that a chatbot that integrated generative reflections and extended interaction was associated with statistically significant quit intentions compared to a chatbot without generative reflections, they also emphasized that of the three attributes measuring quit intentions, only the self-efficacy-related confidence attribute was the best predictor of successful quitting. This finding is supported by other studies showing that confidence is a significant predictor of smoking behavior, as the more confident an individual is, the more likely he or she is to attempt and succeed in quitting smoking [47,48]. The only study that measured reductions in smoking and/or vaping was conducted by Haug et al. [37]. This study found that adolescent use of a chatbot did not contribute to reductions in smoking or vaping. Regarding vaping, this finding contradicts that of Graham et al. [17,49]. These authors demonstrated in their studies that a tailored and interactive text-messaging intervention was effective in promoting vaping cessation in both adolescents and young adults [17,49]. This difference in results may be related to the composite nature of the primary outcome measure in the study by Haug et al. [37], which may not account for confounding factors. As for Leeuwis and He [39], their study showed that interaction with a chatbot, regardless of whether it incorporated a motivational interviewing communication style or a confrontational counseling style, did not positively contribute to smoking cessation intention. However, it is noteworthy that in some digital interventions, particularly online smoking cessation interventions, the intention to quit was significantly higher among smokers who successfully quit and those who relapsed compared to persistent smokers [50]. This finding is consistent with the secondary outcome of the study by Leeuwis and He [39], which showed that exposure to the chatbot, regardless of communication style, had a positive effect on smokers’ intention to quit.

4.2. Main Contributions

The current scope of interactive conversational agents available for smoking cessation was previously reported in a scoping review [51], although an update was needed given the rapid development of chatbot technologies in recent years. A systematic review of chatbots for smoking cessation was also published during our review [25], but this review did not include vaping. Like He et al. in their review [25], we found some support for the use of chatbots for smoking cessation. Our review found that compared to other smoking cessation methods, chatbots can lead to increased willingness to quit smoking and vaping, better engagement in treatment, and eventually higher sustained abstinence rates and improved quality of life. Our review also found that chatbots may be perceived as empathetic and may establish an appropriate therapeutic alliance due to their communication skills, which may explain the higher engagement observed. Other systematic reviews of digital health interventions for smoking cessation have reported that participants were generally satisfied with the use of internet-based interventions [42,44]. However, given the small number of included studies and the heterogeneity of outcome measures, it is important to update this review as new studies become available.

4.3. Strengths and Limitations

Neither the previous scoping review [51] nor the systematic review [25] included studies on electronic cigarette vaping, which, like smoking, is a growing public health threat [5,6]. We considered it relevant to include both smoking and vaping behaviors in our review, given their similarities in terms of potential health effects and intervention design. Therefore, our review included an examination of the effectiveness of chatbots in reducing vaping, which is a strength that makes our study original. However, it also highlights a lack of knowledge about the effectiveness and feasibility of this technology in the context of vaping, and whether the effects differ from those of smoking cessation. One of the strengths of this review is that it only considered interventions that used interactive conversational agents that can adapt to the individual, rather than static conversational agents that use a predefined set of questions and answers.
This systematic review has certain limitations. First, the small number of studies found and the variability in their designs and outcome measures limit the ability to make a quantitative synthesis of the reported effects. Unlike the review by He et al. [25], our review considered interactive chatbots, which is why the number of studies included in our review (n = 8) is lower than theirs (n = 13). The fact that there is only one study targeting vaping cessation is another limitation of our review. However, given the similarities and nature of interventions targeting smoking and vaping cessation, it is likely that most of the findings could apply to both smoking and vaping. As e-cigarette vaping is now considered an important public health issue, it is likely that more chatbot interventions for vaping cessation will be implemented, and their results should be incorporated into an update of this review.

5. Conclusions

This systematic mixed-methods review provides an overview of interactive conversational agents for smoking and vaping cessation. This knowledge could be useful for the development of interactive conversational agents better suited to the context of smoking and vaping cessation. While the number of cigarette smokers remains stable worldwide, the growing popularity of vaping among young people may have serious public health implications. Alternative intervention tools for younger generations, such as chatbots, may provide public health professionals with an additional means of reaching them. It is important to continue research on this topic and provide up-to-date evidence to inform policymakers and researchers about the effectiveness and success predictors of interactive conversational agents in smoking and e-cigarette vaping cessation. It is particularly important that future research focuses on understanding the relationship between MI-enabled chatbots and their effectiveness in changing the behavior of smokers and e-cigarette smokers. In addition, researchers need to focus more on understanding the effectiveness of chatbots in vaping cessation.

Author Contributions

Conceptualization, A.L., M.S. and M.-P.G.; methodology, A.L., A.Y., F.B. and M.-P.G.; formal analysis, A.L., S.M.A.R.D., A.Y., J.P., F.N. and F.Y.; writing—original draft preparation, A.L., S.M.A.R.D., A.Y., J.P. and M.-P.G.; writing—review and editing, all authors; supervision, M.-P.G.; project administration, A.L.; funding acquisition, M.-P.G. All authors have read and agreed to the published version of the manuscript.

Funding

This project was funded by a Research Development Grant from the Faculty of Nursing Sciences, Université Laval (grant number SAR-2020-2021).

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Appendix A. Database Search Strategy

Appendix A.1. Search Strategy for Medline (OVID)

  • Medline (OVID)
  • Date of the search: 21-07-2022
  • Database limit: limit results to publications date between 2021-07-23 to 2022-07-21
#Search StrategyResults
1(“chat bot?” or chatterbot? or chatbot? or medbot? or “chatter bot?” or smart bot? or smartbot?).ti,ab,kw526
2(Conversational adj2 (host or coach or avatar or advisor or assistant or interface or avatar or agent? or system or computer or humanoid or character or bot? or AI)).ti,ab355
3((virtual or intelligent or chat or computer or AI or “artificial intelligence” or relational or embodied) adj2 agent?).ti,ab938
41 or 2 or 31582
5exp Smoking/OR Tobacco Use Disorder/OR exp “Tobacco Use Disorder”/OR Electronic Nicotine Delivery Systems/OR Smoking Cessation/OR “Tobacco Use Cessation”/181,214
6(Smoking OR Smoker? OR Tobacco OR Nicotine OR Cigarette? OR Vape* OR Vaping? OR Ecigarette? OR ECig OR “E-Cig”).ti,ab,kw,kf384,819
75 OR 6419,866
84 AND 718
9limit 8 to ed = 20210723–202207213

Appendix A.2. Search Strategy for Embase (Embase.com)

  • Date of the search: 21-07-2022
  • Database limit: limit results to publications date between 2021-07-23 to 2022-07-21
#Search StrategyResults
1(“chat bot$” OR chatterbot$ OR chatbot$ OR medbot$ OR “chatter bot$” OR “smart bot$” OR smartbot$):ti,ab,kw507
2(Conversational NEAR/2 (host OR coach OR avatar OR advisor OR assistant OR interface OR avatar OR agent$ OR system OR computer OR humanoid OR character OR bot$ OR AI)):ti,ab324
3((virtual OR intelligent OR chat OR computer OR AI OR “artificial intelligence” OR relational OR embodied) NEAR/2 agent$):ti,ab964
4#1 OR #2 OR #31612
5‘smoking’/exp OR ‘tobacco dependence’/de OR ‘tobacco use’/exp OR ‘smoking cessation’/de OR ‘electronic cigarette’/de499,263
6(Smoking OR Smoker$ OR Tobacco OR Nicotine OR Cigarette$ OR Vape* OR Vaping$ OR Ecigarette$ OR ECig OR “E-Cig”):ti,ab,kw549,408
7#5 OR #6670,935
8#4 AND #724
9#8 AND [23-07-2021]/sd9

Appendix A.3. Search Strategy for CINAHL

  • Date of the search: 21-07-2022
  • Database limit: limit results to publications date between 2021-07-23 to 2022-07-21
#Search StrategyResults
1TI (“chat bot?” OR chatterbot? OR chatbot? OR medbot? OR “chatter bot?” OR smart bot? OR smartbot?) OR AB (“chat bot?” OR chatterbot? OR chatbot? OR medbot? OR “chatter bot?” OR smart bot? OR smartbot?)281
2TI (Conversational N2 (host OR coach OR avatar OR advisor OR assistant OR interface OR avatar OR agent? OR system OR computer OR humanoid OR character OR bot? OR AI)) OR AB (Conversational N2 (host OR coach OR avatar OR advisor OR assistant OR interface OR avatar OR agent? OR system OR computer OR humanoid OR character OR bot? OR AI))188
3TI ((virtual OR intelligent OR chat OR computer OR AI OR “artificial intelligence” OR relational OR embodied) N2 agent?) OR AB ((virtual OR intelligent OR chat OR computer OR AI OR “artificial intelligence” OR relational OR embodied) N2 agent?)300
4S1 OR S2 OR S3658
5MH “Smoking+” OR MH “Electronic Cigarettes”78,928
6TI (Smoking OR Smoker# OR Tobacco OR Nicotine OR Cigarette# OR Vape* OR Vaping# OR Ecigarette# OR ECig OR “E-Cig”) OR AB (Smoking OR Smoker# OR Tobacco OR Nicotine OR Cigarette# OR Vape* OR Vaping# OR Ecigarette# OR ECig OR “E-Cig”)122,238
7S5 OR S6142,303
8S4 AND S77
9S8 AND DT 20210723-202207211

Appendix A.4. Search Strategy for Web of Science

  • Date of the search: 21-07-2022
  • Database limit: limit results to publications date between 2021-07-23 to 2022-07-21
#Search StrategyResults
1TS = (“chat bot$” OR chatterbot$ OR chatbot$ OR medbot$ OR “chatter bot$” OR smart bot$ OR smartbot$)40,548
2TS = (Conversational NEAR/2 (host OR coach OR avatar OR advisor OR assistant OR interface OR avatar OR agent$ OR system OR computer OR humanoid OR character OR bot$ OR AI))3878
3TS = ((virtual OR intelligent OR chat OR computer OR AI OR “artificial intelligence” OR relational OR embodied) NEAR/2 agent$)16,274
4#1 OR #2 OR #358,623
5TS = (Smoking OR Smoker$ OR Tobacco OR Nicotine OR Cigarette$ OR Vape* OR Vaping$ OR Ecigarette$ OR ECig OR “E-Cig”)526,665
6#4 AND #5130
7Database publications date limit from 2021-07-23 to 2022-07-2122

Appendix A.5. Search Strategy for Inspec (Engineering Village)

  • Date of the search: 21-07-2022
  • Database limit: limit results to publications date between 2021-07-23 to 2022-07-21
#Search StrategyResults
1chatbots WN CV555
2“chat bot*” WN TI OR chatterbot* WN TI OR chatbot* WN TI OR medbot* WN TI OR “chatter bot*” WN TI OR smart bot* WN TI OR smartbot* WN TI OR “chat bot*” WN AU OR chatterbot* WN AU OR chatbot* WN AU OR medbot* WN AU OR “chatter bot*” WN AU OR smart bot* WN AU OR smartbot* WN AU1306
3(Conversational NEAR/2 host) WN TI OR (Conversational NEAR/2 coach) WN TI OR (Conversational NEAR/2 avatar) WN TI OR (Conversational NEAR/2 advisor) WN TI OR (Conversational NEAR/2 assistant) WN TI OR (Conversational NEAR/2 interface) WN TI OR (Conversational NEAR/2 avatar) WN TI OR (Conversational NEAR/2 agent*) WN TI OR (Conversational NEAR/2 system) WN TI OR (Conversational NEAR/2 computer) WN TI OR (Conversational NEAR/2 humanoid) WN TI OR (Conversational NEAR/2 character) WN TI OR (Conversational NEAR/2 bot*) WN TI OR (Conversational NEAR/2 AI) WN TI OR (Conversational NEAR/2 host) WN AU OR (Conversational NEAR/2 coach) WN AU OR (Conversational NEAR/2 avatar) WN AU OR (Conversational NEAR/2 advisor) WN AU OR (Conversational NEAR/2 assistant) WN AU OR (Conversational NEAR/2 interface) WN AU OR (Conversational NEAR/2 avatar) WN AU OR (Conversational NEAR/2 agent*) WN AU OR (Conversational NEAR/2 system) WN AU OR (Conversational NEAR/2 computer) WN AU OR (Conversational NEAR/2 humanoid) WN AU OR (Conversational NEAR/2 character) WN AU OR (Conversational NEAR/2 bot*) WN AU OR (Conversational NEAR/2 AI) WN AU1065
4(virtual NEAR/2 agent) WN TI OR (intelligent NEAR/2 agent) WN TI OR (chat NEAR/2 agent) WN TI OR (computer NEAR/2 agent) WN TI OR (AI NEAR/2 agent) WN TI OR (“artificial intelligence” NEAR/2 agent) WN TI OR (relational NEAR/2 agent) WN TI OR (embodied NEAR/2 agent) WN TI OR (virtual NEAR/2 agent) WN AU OR (intelligent NEAR/2 agent) WN AU OR (chat NEAR/2 agent) WN AU OR (computer NEAR/2 agent) WN AU OR (AI NEAR/2 agent) WN AU OR (“artificial intelligence” NEAR/2 agent) WN AU OR (relational NEAR/2 agent) WN AU OR (embodied NEAR/2 agent) WN AU2075
5#1 OR #2 OR #3 OR #44505
6Tobacco WN CV OR Nicotine WN CV4392
7Smoking WN TI OR Smoker* WN TI OR Tobacco WN TI OR Nicotine WN TI OR Cigarette* WN TI OR Vape* WN TI OR Vaping* WN TI OR Ecigarette* WN TI OR ECig WN TI OR “E-Cig” WN TI OR Smoking WN AB OR Smoker* WN AB OR Tobacco WN AB OR Nicotine WN AB OR Cigarette* WN AB OR Vape* WN AB OR Vaping* WN AB OR Ecigarette* WN AB OR ECig WN AB OR “E-Cig” WN AB11,204
8#6 OR #711,433
9#5 AND #83
10Database publications years limit from 2021 to 20220

References

  1. Global Burden of Disease (Database); Institute of Health Metrics: Washington, DC, USA, 2019.
  2. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2010. Available online: https://stacks.cdc.gov/view/cdc/6067 (accessed on 6 November 2024).
  3. United States Public Health Service, Office of the Surgeon General, Office on Smoking and Health. The Health Consequences of Smoking: A Report of the Surgeon General; US Department of Health and Human Services, Public Health Service: Rockville, MD, USA, 2004. Available online: https://www.ncbi.nlm.nih.gov/books/NBK44695 (accessed on 6 November 2024).
  4. Tammemägi, M.C.; Berg, C.D.; Riley, T.L.; Cunningham, C.R.; Taylor, K.L. Impact of lung cancer screening results on smoking cessation. J. Natl. Cancer. Inst. 2014, 106, dju084. [Google Scholar] [CrossRef] [PubMed]
  5. Tehrani, H.; Rajabi, A.; Ghelichi-Ghojogh, M.; Nejatian, M.; Jafari, A. The prevalence of electronic cigarettes vaping globally: A systematic review and meta-analysis. Arch. Public. Health 2022, 80, 240. [Google Scholar] [CrossRef]
  6. Fadus, M.C.; Smith, T.T.; Squeglia, L.M. The rise of e-cigarettes, pod mod devices, and JUUL among youth: Factors influencing use, health implications, and downstream effects. Drug. Alcohol. Depend. 2019, 201, 85–93. [Google Scholar] [CrossRef]
  7. Jerzyński, T.; Stimson, G.V. Estimation of the global number of vapers: 82 million worldwide in 2021. Drugs. Habits. Soc. Policy. 2023, 24, 91–103. [Google Scholar] [CrossRef]
  8. World Health Organization. Tobacco and Nicotine Industry Tactics Addict Youth for Life. 2024. Available online: https://www.who.int/news/item/23-05-2024-tobacco-and-nicotine-industry-tactics-addict-youth-for-life (accessed on 6 November 2024).
  9. Stephan, Y.; Sutin, A.R.; Luchetti, M.; Caille, P.; Terracciano, A. Cigarette smoking and personality change across adulthood: Findings from five longitudinal samples. J. Res. Personal. 2019, 81, 187–194. [Google Scholar] [CrossRef]
  10. US Department of Health and Human Services. e-Cigarette Use Among Youth and Young Adults: A Report of the Surgeon General; DHHS: Atlanta, GA, USA, 2016.
  11. Goriounova, N.A.; Mansvelder, H.D. Short-and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function. Cold. Spring. Harb. Perspect. Med. 2012, 2, a012120. [Google Scholar] [CrossRef] [PubMed]
  12. Bonilla, A.; Blair, A.J.; Alamro, S.M.; Ward, R.A.; Feldman, M.B.; Dutko, R.A.; Karagounis, T.K.; Johnson, A.L.; Folch, E.E.; Vyas, J.M. Recurrent spontaneous pneumothoraces and vaping in an 18-year-old man: A case report and review of the literature. J. Med. Case. Rep. 2019, 13, 1–6. [Google Scholar] [CrossRef]
  13. Johns Hopkins Medicine. What Does Vaping Do to Your Lungs? 2022. Available online: https://www.hopkinsmedicine.org/health/wellness-and-prevention/what-does-vaping-do-to-your-lungs (accessed on 6 November 2024).
  14. Canadian Cancer Society. Risk Factors for Lung Cancer. 2020. Available online: https://cancer.ca/en/cancer-information/cancer-types/lung/risks#:~:text=About%2072%25%20of%20lung%20cancer,and%20have%20other%20risk%20factors (accessed on 6 November 2024).
  15. Alami, H.; Fortin, J.P.; Gagnon, M.P.; Lamothe, L.; Ghandour, E.K.; Ag Ahmed, M.A.; Roy, D. Cadre Stratégique pour Soutenir l’Evaluation des Projets Complexes et Innovants en Santé Numérique; Sante Publique: Saint-Maurice, France, 2020; Volume 32, pp. 221–228. (In French) [Google Scholar] [CrossRef] [PubMed]
  16. Berg, C.J.; Romm, K.F.; Patterson, B.; Wysota, C.; Abroms, L.C. Appeal of novel cessation intervention ap-proaches among young-adult users of traditional and alternative tobacco products. Tob. Use Insights 2021, 14, 1179173X211041123. [Google Scholar] [CrossRef]
  17. Graham, A.L.; Amato, M.S.; Cha, S.; Jacobs, M.A.; Bottcher, M.M.; Papandonatos, G.D. Effectiveness of a Vaping Cessation Text Message Program Among Young Adult e-Cigarette Users: A Randomized Clinical Trial. JAMA Intern. Med. 2021, 181, 923–930. [Google Scholar] [CrossRef]
  18. Denecke, K.; Tschanz, M.; Dorner, T.L.; May, R. Intelligent conversational agents in healthcare: Hype or hope? Stud. Health Technol. Inf. 2019, 259, 77–84. [Google Scholar]
  19. Montenegro, J.L.Z.; da Costa, C.A.; da Rosa Righi, R. Survey of conversational agents in health. Expert. Syst. Appl. 2019, 129, 56–67. [Google Scholar] [CrossRef]
  20. Tudor Car, L.; Dhinagaran, D.A.; Kyaw, B.M.; Kowatsch, T.; Joty, S.; Theng, Y.; Atun, R. Conversational agents in health care: Scoping review and conceptual analysis. J. Med. Internet. Res. 2020, 22, e17158. [Google Scholar] [CrossRef] [PubMed]
  21. Gabarron, E.; Larbi, D.; Denecke, K.; Årsand, E. What do we know about the use of chatbots for public health? Stud. Health. Technol. Inform. 2020, 270, 796–800. [Google Scholar] [CrossRef] [PubMed]
  22. Parmar, P.; Ryu, J.; Pandya, S.; Sedoc, J.; Agarwal, S. Health-focused conversational agents in person-centered care: A review of apps. NPJ Digit. Med. 2022, 5, 21. [Google Scholar] [CrossRef] [PubMed]
  23. Oh, K.J.; Lee, D.; Ko, B.; Choi, H.J. A chatbot for psychiatric counseling in mental healthcare service based on emotional dialogue analysis and sentence generation. In Proceedings of the 2017 8th IEEE International Conference on Mobile Data Management (MDM), Daejeon, Republic of Korea, 29 May–1 June 2017; pp. 371–375. [Google Scholar] [CrossRef]
  24. Jovanovic, M.; Baez, M.; Casati, F. Chatbots as conversational healthcare services. IEEE Internet. Comput. 2021, 25, 44–51. [Google Scholar] [CrossRef]
  25. He, L.; Balaji, D.; Wiers, R.W.; Antheunis, M.L.; Krahmer, E. Effectiveness and acceptability of conversational agents for smoking cessation: A systematic review and meta-analysis. Nicotine. Tob. Res. Off. J. Soc. Res. Nicotine. Tob. 2022, 24, ntac281. [Google Scholar] [CrossRef]
  26. Sasseville, M.; Barony Sanchez, R.H.; Yameogo, A.R.; Bergeron-Drolet, L.A.; Bergeron, F.; Gagnon, M.P. Interactive Conversational Agents for Health Promotion, Prevention, and Care: Protocol for a Mixed Methods Systematic Scoping Review. JMIR Res. Protoc. 2022, 11, e40265. [Google Scholar] [CrossRef]
  27. Lachance, A.; Yameogo, A.R.; Plaisimond, J.; Da, S.; Bergeron, F.; Sasseville, M.; Gagnon, M. Interactive conversational agents for cigarette smoking and vaping cessation: A protocol for a mixed-methods systematic scoping review. Preprints 2024, 11, 2024092176. [Google Scholar] [CrossRef]
  28. Stern, C.; Lizarondo, L.; Carrier, J.; Godfrey, C.; Rieger, K.; Salmond, S.; Apostolo, J.; Kirkpatrick, P.; Loveday, H. Methodological guidance for the conduct of mixed methods systematic reviews. JBI Evid. Implement. 2021, 19, 120–129. [Google Scholar] [CrossRef]
  29. Selçuk, A.A. A guide for systematic reviews: PRISMA. Turk. Arch. Otorhinolaryngol. 2019, 10, 57–58. [Google Scholar] [CrossRef]
  30. Covidence. Veritas Health Innovation. Available online: https://www.covidence.org/ (accessed on 3 October 2022).
  31. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 29, 372. [Google Scholar] [CrossRef]
  32. Pluye, P.; Robert, E.; Cargo, M.; Bartlett, G.; O’Cathain, A.; Griffiths, F.F.; Boardman, F.; Gagnon, M.P.; Rousseau, M.C. Proposal: A Mixed Methods Appraisal Tool for Systematic Mixed Studies Reviews. 2011. Available online: http://mixedmethodsappraisaltoolpublic.pbworks.com (accessed on 15 November 2013).
  33. Hong, Q.N.; Pluye, P.; Fàbregues, S.; Bartlett, G.; Boardman, F.; Cargo, M.; Dagenais, P.; Gagnon, M.P.; Griffiths, F.; Nicolau, B.; et al. Improving the content validity of the mixed methods ap-praisal tool: A modified e-Delphi study. J. Clin. Epidemiol. 2019, 111, 49–59. [Google Scholar] [CrossRef] [PubMed]
  34. Abdullah, A.S.; Gaehde, S.; Bickmore, T. A Tablet Based Embodied Conversational Agent to Promote Smoking Cessation among Veterans: A Feasibility Study. J. Epidemiol. Glob. Health 2018, 8, 225–230. [Google Scholar] [CrossRef]
  35. Alphonse, A.; Stewart, K.; Brown, J.; Perski, O. Exploring Users’ Experiences With a Quick-Response Chatbot Within a Popular Smoking Cessation Smartphone App: Semistructured Interview Study. JMIR Form. Res. 2022, 6, e36869. [Google Scholar] [CrossRef]
  36. Brown, A.; Kumar, A.T.; Melamed, O.; Ahmed, I.; Wang, Y.H.; Deza, A.; McKenzie, K.; Hurst, M. A Motivational Interviewing Chatbot With Generative Reflections for Increasing Readiness to Quit Smoking: Iterative Development Study. JMIR Ment. Health 2023, 10, e49132. [Google Scholar] [CrossRef]
  37. Haug, S.; Boumparis, N.; Wenger, A.; Schaub, M.P.; Paz Castro, R. Efficacy of a Mobile App-Based Coaching Program for Addiction Prevention among Apprentices: A Cluster-Randomized Controlled Trial. Int. J. Environ. Res. Public Health 2022, 19, 15730. [Google Scholar] [CrossRef]
  38. He, L.; Basar, E.; Wiers, R.W.; Antheunis, M.L.; Krahmer, E. Can chatbots help to motivate smoking cessation? A study on the effectiveness of motivational interviewing on engagement and therapeutic alliance. BMC Public. Health. 2022, 22, 1–14. [Google Scholar] [CrossRef] [PubMed]
  39. Leeuwis, L.; He, L. Hi, I’m Cecil(y) the Smoking Cessation Chatbot: The Effectiveness of Motivational Interviewing and Confrontational Counseling Chatbots and the Moderating Role of the Need for Autonomy and Self-efficacy. In Chatbot Research and Design; Følstad, A., Araujo, T., Papadopoulos, S., Law, E.L.C., Luger, E., Goodwin, M., Hobert, S., Brandtzaeg, P.B., Eds.; Springer International Publishing: Cham, Switzerland, 2023; pp. 3–17. [Google Scholar]
  40. Olano-Espinosa, E.; Avila-Tomas, J.F.; Minue-Lorenzo, C.; Matilla-Pardo, B.; Serrano, M.E.S.; Martinez-Suberviola, F.J.; Gil-Conesa, M.; Del Cura-González, I. Effectiveness of a Conversational Chatbot (Dejal@bot) for the Adult Population to Quit Smoking: Pragmatic, Multicenter, Controlled, Randomized Clinical Trial in Primary Care. JMIR MHealth. UHealt. 2022, 10, e34273. [Google Scholar] [CrossRef]
  41. 41. Perski, O.; Crane, D.; Beard, E.; Brown, J. Does the addition of a supportive chatbot promote user engagement with a smoking cessation app? An experimental study. Digit. Health. 2019, 5, 2055207619880676. [Google Scholar] [CrossRef]
  42. Miller, W.R.; Rollnick, S. Ten things that motivationalinterviewing is not. Behav. Cogn. Psychother. 2009, 37, 129–140. [Google Scholar] [CrossRef]
  43. Do, H.P.; Tran, B.X.; Le Pham, Q.; Nguyen, L.H.; Tran, T.T.; Latkin, C.A.; Dunne, M.P.; Baker, P.R. Which eHealth interventions are most effective for smoking cessation? A systematic review. Patient Prefer. Adherence 2018, 12, 2065–2084. [Google Scholar] [CrossRef] [PubMed]
  44. Stead, L.F.; Koilpillai, P.; Fanshawe, T.R.; Lancaster, T. Combined pharmacotherapy and behavioural inter-ventions for smoking cessation. Cochrane. Database. Syst. Rev. 2016, 3, CD008286. [Google Scholar] [CrossRef]
  45. Lindson, N.; Thompson, T.P.; Ferrey, A.; Lambert, J.D.; Aveyard, P. Motivational interviewing for smoking cessation. Cochrane. Database. of Syst. Rev. 2019, 7, CD006936. [Google Scholar] [CrossRef]
  46. Bendotti, H.; Lawler, S.; Ireland, D.; Gartner, C.; Marshall, H.M. Co-Designing a Smoking Cessation Chatbot: Focus Group Study of End Users and Smoking Cessation Professionals. JMIR Hum. Factors 2024, 11, e56505. [Google Scholar] [CrossRef] [PubMed]
  47. Gwaltney, C.J.; Metrik, J.; Kahler, C.W.; Shiffman, S. Self-Efficacy and Smoking Cessation: A Meta-Analysis. Psychol Addict Behave. J. Soc. Psychol. Addict. Behav. 2009, 23, 56. Available online: https://www-ncbi-nlm-nih-gov.acces.bibl.ulaval.ca/pmc/articles/PMC3829471/ (accessed on 19 September 2024).
  48. Von Ah, D.; Ebert, S.; Ngamvitroj, A.; Park, N.; Kang, D.H. Factors Related to Cigarette Smoking Initiation and Use among College Students. Tob. Induc. Dis. 2005, 3, 27. [Google Scholar] [CrossRef]
  49. Graham, A.L.; Cha, S.; Jacobs, M.A.; Amato, M.S.; Funsten, A.L.; Edwards, G.; McCarthy, M. A Vaping Cessation Text Message Program for Adolescent E-Cigarette Users: A Randomized Clinical Trial. JAMA 2024, 332, 713–721. [Google Scholar] [CrossRef] [PubMed]
  50. Smit, E.S.; Hoving, C.; Schelleman-Offermans, K.; West, R.; de Vries, H. Predictors of successful and unsuccessful quit attempts among smokers motivated to quit. Addict. Behav. 2014, 39, 1318–1324. [Google Scholar] [CrossRef]
  51. Leung, T.; Arnold, V.; Reinfelde, M.; Perski, O.; Cummins, K.; Whittaker, R.; Dobson, R.; Garner, K. Chatbots for smoking cessation: Scoping review. J. Med. Internet Res. 2022, 24, e35556. [Google Scholar] [CrossRef]
Mti 08 00101 g001
Figure 1. PRISMA flow diagram for inclusion of studies.
Figure 1. PRISMA flow diagram for inclusion of studies.
Mti 08 00101 g001
Table 1. Characteristics of included studies.
Table 1. Characteristics of included studies.
StudiesCountryYearTargeted
Behavior		Study PopulationParticipantsTechnology NameFunctionalitiesComparatorsStudy Design
Abdullah et al., 2018 [34]USA2018Tobacco smokingVeterans receiving medical care at
Boston VA Healthcare System		6Embodied
Conversational Agent (ECA)		Audio, chat,
avatar		No comparatorsProspective cohort study
Alphonse et al., 2022 [35]United Kingdom2022Tobacco smokingSmokers aged ≥ 18 years14Quit CoachChatNo comparatorsSemi-structured interview study
Brown et al., 2023 [36]Canada2023Tobacco smokingCurrent or recent smokers aged ≥ 18 years349MIBotChatNo comparatorsPre–post study
Haug et al., 2022 [37]Switzerland2022Tobacco and e-cigarette smokingSwiss teenagers aged 16–19 attending vocational schools688Ready4lifeChat, quizParticipation in the program without Ready4lifeRandomized controlled trial
He et al., 2022 [38]Netherlands2022Tobacco smokingSmokers aged ≥ 18 years153RobyChatMI chatbot vs.
neutral chatbot		Randomized between-subjects repeated-measures trial
Leeuwis et al., 2023 [39]Netherlands2023Tobacco smokingSmokers aged ≥ 18 years233Cecily (MI chatbot condition)
Cecil (confrontational counseling chatbot condition)		ChatCecil (confrontational counseling chatbot condition)Randomized controlled trial
Olano-
Espinosa et al., 2022 [40]		Spain2022Tobacco smokingSmokers aged ≥ 18 years513Dejal@botAudio, chat, voiceChatbot vs. usual
clinical practice		Randomized clinical trial
Perski et al., 2019 [41]UK2019Tobacco smokingSmokers aged ≥ 18 years57,214Smoke Free (App)Chat, voiceSmoke Free with
supportive chatbot vs. Smoke Free
without chatbot		Randomized
community trial
Table 2. Reported effects on patient outcomes.
Table 2. Reported effects on patient outcomes.
StudiesContinuous
Abstinence		Motivation
to Quit		EngagementTherapeutic AlliancePerceived EmpathyPerceived
Communication Competence		Quality of LifeReadiness to QuitIntention to QuitSmoking/Vaping Reduction
Brown et al., 2023 [36]----✓--✓--
Haug et al., 2022 [37]---------X
He et al., 2022 [38]-✓000✓----
Leeuwis et al., 2023 [39]--------X-
Olano-
Espinosa et al., 2022 [40]		✓-✓---✓---
Perski et al., 2019 [41]✓-✓-------
Legend: ✓ = positive effect; X = negative effect; 0 = neutral effect; - = not evaluated by the study.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lachance, A.; Da, S.M.A.R.; Yameogo, A.; Plaisimond, J.; Naye, F.; Yousefi, F.; Bergeron, F.; Sasseville, M.; Gagnon, M.-P. Interactive Conversational Agents for Cigarette-Smoking and Vaping Cessation: A Mixed-Methods Systematic Review. Multimodal Technol. Interact. 2024, 8, 101. https://doi.org/10.3390/mti8110101

AMA Style

Lachance A, Da SMAR, Yameogo A, Plaisimond J, Naye F, Yousefi F, Bergeron F, Sasseville M, Gagnon M-P. Interactive Conversational Agents for Cigarette-Smoking and Vaping Cessation: A Mixed-Methods Systematic Review. Multimodal Technologies and Interaction. 2024; 8(11):101. https://doi.org/10.3390/mti8110101

Chicago/Turabian Style

Lachance, Anthony, Sié Mathieu Aymar Romaric Da, Achille Yameogo, James Plaisimond, Florian Naye, Farzaneh Yousefi, Frédéric Bergeron, Maxime Sasseville, and Marie-Pierre Gagnon. 2024. "Interactive Conversational Agents for Cigarette-Smoking and Vaping Cessation: A Mixed-Methods Systematic Review" Multimodal Technologies and Interaction 8, no. 11: 101. https://doi.org/10.3390/mti8110101

APA Style

Lachance, A., Da, S. M. A. R., Yameogo, A., Plaisimond, J., Naye, F., Yousefi, F., Bergeron, F., Sasseville, M., & Gagnon, M. -P. (2024). Interactive Conversational Agents for Cigarette-Smoking and Vaping Cessation: A Mixed-Methods Systematic Review. Multimodal Technologies and Interaction, 8(11), 101. https://doi.org/10.3390/mti8110101

Article Metrics

Back to TopTop